DAWN
COM:DAYONEBIO
Day One Bio
- Stock
7.74
−2.03%
−0.16
Last Close
7.90
25/04 20:00
Market Cap
784.48M
Beta: -
Volume Today
729.05K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
average inventory | ||||||
average payables | 135.50K - | 973K 618.08% | 1.00M 2.98% | 1.42M 41.52% | ||
average receivables | ||||||
book value per share | -0.25 - | -1.29 407.87% | -3.45 167.46% | -4.12 19.42% | 0.00 100.11% | |
capex per share | -0.00 - | -0.22 9,788.56% | -0.00 99.82% | -0.00 99.29% | ||
capex to depreciation | -0.59 - | -40.20 6,673.00% | -0.05 99.88% | -0.58 1,094.46% | ||
capex to operating cash flow | 0.01 - | 0.16 2,316.52% | 0.00 99.86% | 0.00 544.59% | ||
capex to revenue | ||||||
cash per share | 0.65 - | 1.04 59.99% | 7.69 639.37% | 5.23 32.03% | 0.00 99.91% | |
days of inventory on hand | ||||||
days payables outstanding | ||||||
days sales outstanding | ||||||
debt to assets | 0.01 - | 0.00 91.38% | 0.00 206.83% | 0.00 53.42% | ||
debt to equity | -0.01 - | -0.00 76.73% | -0.00 74.70% | 0.00 139.05% | ||
dividend yield | ||||||
earnings yield | -0.01 - | -0.04 175.34% | -0.11 175.81% | -0.09 17.05% | -0.00 99.83% | |
enterprise value | 960.40M - | 944.40M 1.67% | 338.70M 64.14% | 1.32B 291.03% | 1.16T 87,823.52% | |
enterprise value over ebitda | -64.43 - | -69.15 7.33% | -4.66 93.27% | -9.02 93.62% | -5.65K 62,583.22% | |
ev to operating cash flow | -212.71 - | -70.01 67.09% | -6.98 90.03% | -12.05 72.74% | -7.93K 65,683.53% | |
ev to sales | ||||||
free cash flow per share | -0.11 - | -0.32 200.80% | -1.53 373.42% | -1.68 9.74% | -0.00 99.89% | |
free cash flow yield | -0.00 - | -0.01 200.80% | -0.09 560.26% | -0.08 14.07% | -0.00 99.84% | |
graham net net | -0.12 - | -1.20 871.23% | 7.46 721.48% | 4.97 33.38% | 0.00 99.92% | |
graham number | 1.41 - | 5.29 273.95% | 12.16 129.99% | 13.68 12.48% | 0.02 99.89% | |
income quality | 0.27 - | 0.31 15.73% | 0.67 116.85% | 0.77 15.83% | 0.78 0.59% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | |
interest coverage | -7.18 - | -459.40 6,301.70% | -18.19K 3,858.59% | -30.95 99.83% | ||
interest debt per share | 0.05 - | 0.01 79.20% | 0.01 41.03% | 0.08 1,301.09% | 0.00 99.99% | |
inventory turnover | ||||||
invested capital | -0.01 - | -0.00 76.73% | -0.00 74.70% | 0.00 139.05% | ||
market cap | 987.73M - | 987.73M 0% | 622.79M 36.95% | 1.41B 126.22% | 1.16T 82,569.56% | |
net current asset value | -5.19M - | -49.09M 846.64% | 280.69M 671.76% | 330.85M 17.87% | 345.77M 4.51% | |
net debt to ebitda | 1.83 - | 3.17 73.01% | 3.91 23.11% | 0.57 85.28% | 1.12 94.49% | |
net income per share | -0.35 - | -0.96 175.34% | -1.91 97.76% | -2.02 5.93% | -0.00 99.88% | |
operating cash flow per share | -0.11 - | -0.32 198.76% | -1.31 309.21% | -1.68 27.80% | -0.00 99.89% | |
payables turnover | ||||||
receivables turnover | ||||||
research and ddevelopement to revenue | ||||||
return on tangible assets | -0.54 - | -0.89 64.86% | -0.24 72.60% | -0.38 55.79% | -0.50 32.67% | |
revenue per share | ||||||
roe | 1.38 - | 0.75 45.78% | 0.55 26.06% | 0.49 11.29% | -0.55 211.22% | |
roic | 1.21 - | 0.24 80.29% | 0.55 132.50% | 0.51 8.09% | -0.59 216.43% | |
sales general and administrative to revenue | ||||||
shareholders equity per share | -0.25 - | -1.29 407.87% | -3.45 167.46% | -4.12 19.42% | 0.00 100.11% | |
stock based compensation to revenue | ||||||
tangible asset value | -5.19M - | -48.50M 835.27% | 281.15M 679.65% | 332.04M 18.10% | 346.54M 4.37% | |
tangible book value per share | -0.12 - | -1.15 835.27% | 7.61 759.17% | 5.07 33.32% | 0.00 99.91% | |
working capital | 25.32M - | 43.08M 70.14% | 280.71M 551.68% | 331.26M 18.01% | 345.77M 4.38% |
All numbers in USD (except ratios and percentages)